CREO Creo Medical Group PLC

0.1210USD9.200 GBp · LSE-6.60%Mkt Cap: 54.34M USDP/E: —

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an ener…

Key Statistics

Company
Market Cap54.34M USD
Enterprise Value49.62M USD
Revenue (TTM)9.21M USD
Gross Profit3.16M USD
Net Income (TTM)6.97M USD
Revenue/Share0.02 USD
Last Price0.1210 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees104
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINGB00BZ1BLL44
Valuation
P/E (Trailing)—
P/E (Forward)-7.08
PEG—
EV/EBITDA-2.23
EV/Revenue5.39
P/S5.90
P/B0.80
EPS (TTM)-0.13 USD
EPS (Forward)-0.02 USD
52W Range
0.000050% of range0.2433
52W High0.2433 USD
52W Low0.0000 USD
Profitability
Gross Margin40.00%
Oper. Margin-250.00%
EBITDA Margin-241.43%
Profit Margin88.33%
ROE10.60%
ROA8.97%
ROIC-46.76%
ROCE-37.64%
Growth
Revenue Growth45.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.12M USD
CapEx (TTM)1.18M USD
FCF Margin-174.11%
FCF Yield-29.49%
Net Debt-4.60M USD
Net Debt/EBITDA0.21
Net Debt/FCF—
Balance Sheet
Debt/Equity0.08
Current Ratio2.79
Quick Ratio2.33
Book Value/Sh0.15 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.7233 USD
Upside (mean)+497.8%
Target Range0.5261 USD – 0.9206 USD
0.5261+497.8% to mean0.9206
# Analysts2
Ownership
Shares Out.449.14M
Float370.05M
Insiders6.94%
Institutions45.41%
Technical
SMA 500.1456 (-16.9%)
SMA 2000.1676 (-27.8%)
Beta0.94
S&P 52W Chg12.00%
Avg Vol (30d)348.84K
Avg Vol (10d)416.22K
Technical Indicators
RSI (14)17.4
MACD-0.3859
MACD Signal-0.2697
MACD Hist.-0.1162
BB Upper0.1563 USD
BB Middle0.1397 USD
BB Lower0.1230 USD
BB Width23.86%
ATR (14)0.0066 USD
Vol Ratio (20d)3.33x

About Creo Medical Group (LON: CREO)

›

Creo Medical Group (LON: CREO) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 104 employees.

The shares were at 9.200 GBp on 20 November 2026, down 14.4% over 52 weeks.

Its market capitalisation is 41.32M GBP.

Creo Medical Group reports return on equity of 10.6%, an operating margin of -250.0% and revenue up 45.5% year over year.

It holds more cash than debt, a net cash position of 3.50M GBP. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.